Ulrich Bothe

448 total citations
13 papers, 335 citations indexed

About

Ulrich Bothe is a scholar working on Radiology, Nuclear Medicine and Imaging, Molecular Biology and Materials Chemistry. According to data from OpenAlex, Ulrich Bothe has authored 13 papers receiving a total of 335 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Radiology, Nuclear Medicine and Imaging, 4 papers in Molecular Biology and 3 papers in Materials Chemistry. Recurrent topics in Ulrich Bothe's work include Boron Compounds in Chemistry (6 papers), Radiopharmaceutical Chemistry and Applications (6 papers) and Boron and Carbon Nanomaterials Research (3 papers). Ulrich Bothe is often cited by papers focused on Boron Compounds in Chemistry (6 papers), Radiopharmaceutical Chemistry and Applications (6 papers) and Boron and Carbon Nanomaterials Research (3 papers). Ulrich Bothe collaborates with scholars based in Germany, United Kingdom and Japan. Ulrich Bothe's co-authors include Lutz F. Tietze, Ulrich Griesbach, Anne Mengel, K. Asadullah, Matthias Gaestel, Ingrid Schuberth, Hiroyuki Nakamura, Yoshinori Yamamoto, Munekazu NAKAICHI and Alberto Marra and has published in prestigious journals such as Cancer Research, Journal of Medicinal Chemistry and Chemistry - A European Journal.

In The Last Decade

Ulrich Bothe

13 papers receiving 321 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ulrich Bothe Germany 9 187 106 87 83 33 13 335
Robert Kuhnert Germany 9 365 2.0× 129 1.2× 75 0.9× 120 1.4× 47 1.4× 13 439
Michele Iori Italy 11 137 0.7× 67 0.6× 66 0.8× 29 0.3× 67 2.0× 19 332
Sven Stadlbauer Germany 10 194 1.0× 46 0.4× 64 0.7× 61 0.7× 72 2.2× 26 289
Satoshi Kasaoka Japan 10 241 1.3× 171 1.6× 104 1.2× 18 0.2× 32 1.0× 16 436
Hidemitsu Minegishi Japan 11 93 0.5× 54 0.5× 188 2.2× 85 1.0× 36 1.1× 15 348
Lutz F. Schweiger United Kingdom 12 173 0.9× 33 0.3× 111 1.3× 75 0.9× 77 2.3× 21 436
D. Scott Wilbur United States 8 252 1.3× 15 0.1× 111 1.3× 80 1.0× 56 1.7× 10 371
Heike Radeke United States 10 321 1.7× 30 0.3× 84 1.0× 96 1.2× 15 0.5× 14 517
Pascal Häfliger Switzerland 8 126 0.7× 23 0.2× 239 2.7× 34 0.4× 109 3.3× 9 449
Athanasios Glekas United States 9 83 0.4× 24 0.2× 155 1.8× 98 1.2× 90 2.7× 11 409

Countries citing papers authored by Ulrich Bothe

Since Specialization
Citations

This map shows the geographic impact of Ulrich Bothe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ulrich Bothe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ulrich Bothe more than expected).

Fields of papers citing papers by Ulrich Bothe

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ulrich Bothe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ulrich Bothe. The network helps show where Ulrich Bothe may publish in the future.

Co-authorship network of co-authors of Ulrich Bothe

This figure shows the co-authorship network connecting the top 25 collaborators of Ulrich Bothe. A scholar is included among the top collaborators of Ulrich Bothe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ulrich Bothe. Ulrich Bothe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Langer, Gernot, Christiane Otto, Ulrich Bothe, et al.. (2023). Discovery and In Vitro Characterization of BAY 2686013, an Allosteric Small Molecule Antagonist of the Human Pituitary Adenylate Cyclase-Activating Polypeptide Receptor. Molecular Pharmacology. 104(3). 105–114. 1 indexed citations
2.
Walter, Daryl S., Alexis Laux‐Biehlmann, Christopher E. Pearson, et al.. (2023). Discovery of BAY-390, a Selective CNS Penetrant Chemical Probe as Transient Receptor Potential Ankyrin 1 (TRPA1) Antagonist. Journal of Medicinal Chemistry. 66(2). 1583–1600. 15 indexed citations
3.
Nagel, Jens, Olaf Peters, Antonius ter Laak, et al.. (2019). Identification of a Benzimidazolecarboxylic Acid Derivative (BAY 1316957) as a Potent and Selective Human Prostaglandin E2 Receptor Subtype 4 (hEP4-R) Antagonist for the Treatment of Endometriosis. Journal of Medicinal Chemistry. 62(5). 2541–2563. 18 indexed citations
4.
Islam, Imadul, Shendong Yuan, Christopher W. West, et al.. (2018). Discovery of selective urokinase plasminogen activator (uPA) inhibitors as a potential treatment for multiple sclerosis. Bioorganic & Medicinal Chemistry Letters. 28(20). 3372–3375. 4 indexed citations
5.
Lange, Martin, Antje M. Wengner, Ulrich Bothe, et al.. (2018). Abstract 1887: Preclinical evaluation of a novel interleukin-1 receptor-associated kinase 4 (IRAK4) inhibitor in combination with PI3K inhibitor copanlisib or BTK inhibitors in ABC-DLBCL. Cancer Research. 78(13_Supplement). 1887–1887. 1 indexed citations
6.
Gaestel, Matthias, Anne Mengel, Ulrich Bothe, & K. Asadullah. (2007). Protein Kinases as Small Molecule Inhibitor Targets in Inflammation. Current Medicinal Chemistry. 14(21). 2214–2234. 78 indexed citations
7.
Tietze, Lutz F., Ulrich Griesbach, Ingrid Schuberth, et al.. (2003). Novel Carboranyl C‐Glycosides for the Treatment of Cancer by Boron Neutron Capture Therapy. Chemistry - A European Journal. 9(6). 1296–1302. 46 indexed citations
8.
Tietze, Lutz F., Ulrich Griesbach, Ulrich Bothe, Hiroyuki Nakamura, & Yoshinori Yamamoto. (2002). Novel Carboranes with a DNA Binding Unit for the Treatment of Cancer by Boron Neutron Capture Therapy. ChemBioChem. 3(2-3). 219–225. 37 indexed citations
9.
Tietze, Lutz F., Ulrich Bothe, Ulrich Griesbach, et al.. (2001). Carboranyl Bisglycosides for the Treatment of Cancer by Boron Neutron Capture Therapy. ChemBioChem. 2(5). 326–334. 27 indexed citations
10.
Tietze, Lutz F., Ulrich Bothe, Ulrich Griesbach, et al.. (2001). ortho-Carboranyl Glycosides for the Treatment of Cancer by Boron Neutron Capture Therapy. Bioorganic & Medicinal Chemistry. 9(7). 1747–1752. 35 indexed citations
11.
Bothe, Ulrich, Hans Christian Rudbeck, David Tanner, & Mogens Johannsen. (2001). A novel stereoselective synthesis of N-heterocycles by intramolecular hydrovinylationElectronic supplementary information (ESI) available: 1H and 13C NMR spectra of compounds 1a–f, 2a–d, 3–5, 8–10. See http://www.rsc.org/suppdata/p1/b1/b108310d/. Journal of the Chemical Society Perkin Transactions 1. 3305–3311. 2 indexed citations
12.
Tietze, Lutz F., Ulrich Bothe, & Ingrid Schuberth. (2000). Preparation of a New Carboranyl Lactoside for the Treatment of Cancer by Boron Neutron Capture Therapy: Synthesis and Toxicity of Fluoro Carboranyl Glycosides for in vivo19F-NMR Spectroscopy. Chemistry - A European Journal. 6(5). 836–842. 24 indexed citations
13.
Tietze, Lutz F. & Ulrich Bothe. (1998). Ortho-Carboranyl Glycosides of Glucose, Mannose, Maltose and Lactose for Cancer Treatment by Boron Neutron-Capture Therapy. Chemistry - A European Journal. 4(7). 1179–1183. 47 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026